Performance characteristics of a new synthetic APTT reagent.
Performance characteristics of a totally synthetic activated partial thromboplastin time (APTT) reagent, recently available commercially, were evaluated and compared with a rabbit-brain extracted reagent. We found that the synthetic reagent, Synthasil, returned significantly higher normal APTT values than the brain-extracted reagent, Thrombosil. APTT ratios (APTT patients/normal mean APTT), yielded by Synthasil were higher in the majority of patients receiving heparin therapy. Synthasil also returned longer APTT values than did Thrombosil on normal plasma spiked with heparin. On patients with lupus anticoagulants, APTTs assayed with Synthasil were generally longer than with Thrombosil. However, the differences disappeared when APTT values were converted to ratios. Factors XII-, XI-, IX- and VIII-deficient plasmas supplemented with normal plasma to yield activities of 2-50%, generally gave longer APTTs with Synthasil than with Thrombosil. However, this was not always the case on plasmas from haemophilias A and B patients. No reduction in Synthasil activity was noted after the reagent had been left at 24 degrees C for 28 days.
Ts'ao
C
C
Hemostasis Laboratory, Northwestern Memorial Hospital, Chicago, Illinois, USA.
Neofotistos
D
D
Oropeza
M
M
Rogan
M
M
Santos
M
M
D020147:Coagulation Protein Disorders / Q000175:diagnosis*; D004355:Drug Stability; D006467:Hemophilia A / Q000175:diagnosis; D002836:Hemophilia B / Q000175:diagnosis; D006493:Heparin / Q000097:blood*; D006801:Humans; D007202:Indicators and Reagents; D016014:Linear Models; D016682:Lupus Coagulation Inhibitor / Q000032:analysis; D010314:Partial Thromboplastin Time; D012680:Sensitivity and Specificity
D007202:Indicators and Reagents; D016682:Lupus Coagulation Inhibitor; D006493:Heparin